Three Essays on Hypertension Prevention and Medical Product Safety in China and the United States

I know it sounds technical and esoteric, but this dissertation by Ying Liu at the RAND Graduate School is worth reading even if you just want to read the last essay. In that piece, Liu examines the state of China’s drug safety regime in the wake of the scandals between 2006 and 2008 that led to the sacking of China’s senior pharmaceutical regulator. The author looks at what has been fixed – and what has not – since China’s drug safety last made global headlines, providing a subtle warning about the problems that may yet come from that sector.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s